Cargando…

Luteolin Synergistically Enhances Antitumor Activity of Oxaliplatin in Colorectal Carcinoma via AMPK Inhibition

Luteolin is a naturally-occurring polyphenolic compound that is known to have antioxidative and antitumor activities in vitro. This study aimed to examine the in vivo anticancer efficacy of luteolin in conjunction with oxaliplatin treatment using a colorectal carcinoma xenograft mouse model. HCT116...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jang, Chan Ho, Moon, Nayoung, Lee, Jinkyung, Kwon, Min Jeong, Oh, Jisun, Kim, Jong-Sang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030203/ https://www.ncbi.nlm.nih.gov/pubmed/35453311 http://dx.doi.org/10.3390/antiox11040626

Ejemplares similares

Luteolin Shifts Oxaliplatin-Induced Cell Cycle Arrest at G(0)/G(1) to Apoptosis in HCT116 Human Colorectal Carcinoma Cells
por: Jang, Chan Ho, et al.
Publicado: (2019)

Quercetin-Induced Glutathione Depletion Sensitizes Colorectal Cancer Cells to Oxaliplatin
por: Lee, Jinkyung, et al.
Publicado: (2023)

Combination of oncolytic adenovirus and luteolin exerts synergistic antitumor effects in colorectal cancer cells and a mouse model
por: Xiao, Boduan, et al.
Publicado: (2017)

Liposome encapsulated luteolin showed enhanced antitumor efficacy to colorectal carcinoma
por: Wu, Guixia, et al.
Publicado: (2018)

Role of AMPK in Regulation of Oxaliplatin-Resistant Human Colorectal Cancer
por: Park, Sun Young, et al.
Publicado: (2022)

Synergistic Antitumor Effects of Endostar in Combination with Oxaliplatin via Inhibition of HIF and CXCR4 in the Colorectal Cell Line SW1116
por: Jin, Fengyan, et al.
Publicado: (2012)

Synergistic effect of sodium butyrate and oxaliplatin on colorectal cancer
por: Shuwen, Han, et al.
Publicado: (2022)

Luteolin Suppresses the Proliferation of Gastric Cancer Cells and Acts in Synergy with Oxaliplatin
por: Ren, Li-Qun, et al.
Publicado: (2020)

Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy
por: Tsubaki, Masanobu, et al.
Publicado: (2023)

Effect and Comparison of Luteolin and Its Derivative Sodium Luteolin-4′-sulfonate on Adipogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells through AMPK-Mediated PPARγ Signaling
por: Oh, Jung Hwan, et al.
Publicado: (2020)

Ursolic acid synergistically enhances the therapeutic effects of oxaliplatin in colorectal cancer
por: Shan, Jianzhen, et al.
Publicado: (2016)

The synergistic effects of oxaliplatin and piperlongumine on colorectal cancer are mediated by oxidative stress
por: Chen, WeiQian, et al.
Publicado: (2019)

Capsaicin exerts synergistic antitumor effect with sorafenib in hepatocellular carcinoma cells through AMPK activation
por: Bort, Alicia, et al.
Publicado: (2017)

Synergistic antitumor activity of regorafenib and rosuvastatin in colorectal cancer
por: Yuan, Tao, et al.
Publicado: (2023)

Synergistic Combination of Luteolin and Asiatic Acid on Cervical Cancer In Vitro and In Vivo
por: Chen, Ya-Hui, et al.
Publicado: (2023)

A Muti-center, Randomized Phase II Study of Oxaliplatin and S-1 versus Capecitabine and Oxaliplatin in Patients with Metastatic Colorectal Cancer
por: Kim, Jung Han, et al.
Publicado: (2015)

TRAIL Gene-Armed Oncolytic Poxvirus and Oxaliplatin Can Work Synergistically against Colorectal Cancer
por: Ziauddin, Mohammed F, et al.
Publicado: (2010)

A Synergistic Combination of DHA, Luteolin, and Urolithin A Against Alzheimer’s Disease
por: Jayatunga, Dona P. W., et al.
Publicado: (2022)

Serum Concentration of Genistein, Luteolin and Colorectal Cancer Prognosis
por: Jiang, Ruijingfang, et al.
Publicado: (2019)

Luteolin improves vasoconstriction function and survival of septic mice via AMPK/NF-κB pathway
por: Liu, Bin, et al.
Publicado: (2023)

Synergistic Antitumor Effect of Dichloroacetate in Combination with 5-Fluorouracil in Colorectal Cancer
por: Tong, Jingtao, et al.
Publicado: (2011)

Synergistic antitumor effect of brusatol combined with cisplatin on colorectal cancer cells
por: Chen, Hai-Ming, et al.
Publicado: (2018)

Metformin Synergistically Potentiates the Antitumor Effects of Imatinib in Colorectal Cancer Cells
por: Lee, Jaeryun, et al.
Publicado: (2017)

Combinatorial Antitumor Activity of Oxaliplatin with Epigenetic Modifying Agents, 5-Aza-CdR and FK228, in Human Gastric Cancer Cells
por: Park, Jong Kook, et al.
Publicado: (2018)

Synergistic antitumor effect of resveratrol and sorafenib on hepatocellular carcinoma through PKA/AMPK/eEF2K pathway
por: Gao, Meili, et al.
Publicado: (2021)

Luteolin Induces Selective Cell Death of Human Pluripotent Stem Cells
por: Go, Young-Hyun, et al.
Publicado: (2020)

Chidamide and Oxaliplatin Synergistically Inhibit Colorectal Cancer Growth by Regulating the RPS27A-MDM2-P53 Axis
por: Li, Zhaopeng, et al.
Publicado: (2023)

Thermogel Delivers Oxaliplatin and Alendronate in situ for Synergistic Osteosarcoma Therapy
por: Sun, Yifu, et al.
Publicado: (2020)

Luteolin Promotes Apoptosis of Endometriotic Cells and Inhibits the Alternative Activation of Endometriosis-Associated Macrophages
por: Woo, Jeong-Hwa, et al.
Publicado: (2021)

Synergistic antitumor activity of sorafenib and MG149 in hepatocellular carcinoma cells
por: Moon, Byul, et al.
Publicado: (2022)

The Effect of Cucurbit[7]uril on the Antitumor and Immunomodulating Properties of Oxaliplatin and Carboplatin
por: Pashkina, Ekaterina, et al.
Publicado: (2021)

In Vivo Anti-Inflammatory Potential of Viscozyme(®)-Treated Jujube Fruit
por: Kim, Yoonsu, et al.
Publicado: (2020)

Role of oxaliplatin in the treatment of colorectal cancer
por: Comella, Pasquale, et al.
Publicado: (2009)

Oxaliplatin-Induced Neuropathy in Colorectal Cancer
por: Weickhardt, Andrew, et al.
Publicado: (2011)

Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2
por: Sun, Wei, et al.
Publicado: (2021)

Antitumor Activity of lncRNA NBAT-1 via Inhibition of miR-4504 to Target to WWC3 in Oxaliplatin-Resistant Colorectal Carcinoma
por: Li, Chen, et al.
Publicado: (2022)

ADT‐OH synergistically enhanced the antitumor activity of celecoxib in human colorectal cancer cells
por: Xu, Huangru, et al.
Publicado: (2023)

Augmented Antitumor Effect of Unripe Rubus coreanus Miquel Combined with Oxaliplatin in a Humanized PD-1/PD-L1 Knock-In Colorectal Cancer Mouse Model
por: Lee, Eun-Ji, et al.
Publicado: (2022)

Outpatient-basis Chemotherapy of Oxaliplatin, 5-fluorouracil, and Leucovorin as First-line Treatment for Patients with Metastatic or Recurrent Colorectal Cancer
por: Moon, Joon Ho, et al.
Publicado: (2007)

AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway
por: Pokhrel, Ram Hari, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l61rpbbud233a25i05idl1emb5